An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination
International Immunology · 07.08.2023 · 35 (8) · 353-359
DOI: 10.1093/intimm/dxad014 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunology, online erschienen am 06.05.2023. Verfasst von Ricardo da Silva Antunes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI); La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
In this brief opinion piece, we highlight our studies characterizing adaptive SARS-CoV-2 immune responses in infection and vaccination, and the ability of SARS-CoV-2-specific T cells to recognize emerging variants of concern, and the role of pre-existing cross-reactive T cells. In the context of the debate on correlates of protection, the pandemic’s progression in the past 3 years underlined the need to consider how different adaptive immune responses might differentially contribute to protection from SARS-CoV-2 infection versus COVID-19 disease. Lastly, we discuss how cross-reactive T cell responses may be useful in generating a broad adaptive immunity, recognizing different variants and viral families. Considering vaccines with broadly conserved antigens could improve preparedness for future infectious disease outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI); La Jolla, CA 92037, USA.
- Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, CA, USA.
ORCID-Profile: Ricardo da Silva Antunes
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
da Silva Antunes, R., Grifoni, A., Frazier, A., Weiskopf, D., & Sette, A. (2023). An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination. International Immunology, 35(8), 353-359. https://doi.org/10.1093/intimm/dxad014
Vancouver
da Silva Antunes R, Grifoni A, Frazier A, Weiskopf D, Sette A. An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination. International Immunology. 2023;35(8):353-359. doi:10.1093/intimm/dxad014
BibTeX
@article{daSilvaAntunes2023,
author = {da Silva Antunes, Ricardo and Grifoni, Alba and Frazier, April and Weiskopf, Daniela and Sette, Alessandro},
title = {An update on studies characterizing adaptive immune responses in SARS-CoV-2 infection and COVID-19 vaccination},
journal = {International Immunology},
year = {2023},
volume = {35},
number = {8},
pages = {353--359},
doi = {10.1093/intimm/dxad014}
}
EUVIMED